Elena Colicino1, Erik de Water2, Allan C Just3, Esmeralda Navarro4, Nicolo Foppa Pedretti5, Nia McRae6, Joseph M Braun7, Lourdes Schnaas8, Yanelli Rodríguez-Carmona9, Carmen Hernández10, Marcela Tamayo-Ortiz11, Martha M Téllez-Rojo12, Andrea L Deierlein13, Antonia M Calafat14, Andrea Baccarelli15, Robert O Wright16, Megan K Horton17. 1. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: elena.colicino@mssm.edu. 2. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: erikdewater@gmail.com. 3. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: allan.just@mssm.edu. 4. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: esmeralda.navarro@mssm.edu. 5. Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: nicolo.foppapedretti@mssm.edu. 6. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: nia.x.mcrae@mssm.edu. 7. Department of Epidemiology, Brown University, Providence, RI, United States. Electronic address: joseph_braun_1@brown.edu. 8. National Institute of Perinatology (INPer), Mexico City, Mexico. Electronic address: lschnaas@hotmail.com. 9. Department of Nutritional Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, United States. Electronic address: yanelli@umich.edu. 10. National Institute of Perinatology (INPer), Mexico City, Mexico. Electronic address: karmenhdez@gmail.com. 11. National Institute of Public Health (INSP), Cuernavaca, Mexico. Electronic address: marcela.tamayo@insp.mx. 12. National Institute of Public Health (INSP), Cuernavaca, Mexico. Electronic address: mmtellez@insp.mx. 13. College of Global Public Health, New York University, New York, NY, United States. Electronic address: ald8@nyu.edu. 14. Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: acalafat@cdc.gov. 15. Department of Environmental Health Sciences, Columbia University, New York, NY, United States. Electronic address: andrea.baccarelli@columbia.edu. 16. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: robert.wright@mssm.edu. 17. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: megan.horton@mssm.edu.
Abstract
BACKGROUND: Phthalate exposure has been associated with increased childhood behavioral problems. Existing studies failed to include phthalate replacements and did not account for high correlations among phthalates. Phthalates' exposure is higher in Mexico than in U.S. locations, making it an ideal target population for this study. AIM: To examine associations between 15 maternal prenatal phthalate metabolite concentrations and children's behavioral problems. METHODS: We quantified phthalate metabolites in maternal urine samples from maternal-child dyads (n = 514) enrolled in the Programming Research in Obesity, Growth Environment and Social Stress (PROGRESS) birth cohort in Mexico City. We performed least absolute shrinkage and selection operator (LASSO) regressions to identify associations between specific-gravity adjusted log2-transformed phthalate metabolites and parent-reported 4-6 year old behavior on the Behavior Assessment System for Children (BASC-2), accounting for metabolite correlations. We adjusted for socio-demographic and birth-related factors, and examined associations stratified by sex. RESULTS: Higher prenatal mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) urinary concentrations were associated with increased hyperactivity scores in the overall sample (β = 0.57, 95% CI = 0.17, 1.13) and in girls (β = 0.54, 95% CI = 0.16, 1.08), overall behavioral problems in boys (β = 0.58, 95% CI = 0.20, 1.15), and depression scores in boys (β = 0.44, 95% CI = 0.06, 0.88). Higher prenatal monobenzyl phthalate (MBzP) concentrations were associated with reduced hyperactivity scores in girls (ß = -0.54, 95% CI = -1.08, -0.21). DISCUSSION: Our findings suggested that prenatal concentrations of phthalates and their replacements altered child neurodevelopment and those associations may be influenced sex.
BACKGROUND: Phthalate exposure has been associated with increased childhood behavioral problems. Existing studies failed to include phthalate replacements and did not account for high correlations among phthalates. Phthalates' exposure is higher in Mexico than in U.S. locations, making it an ideal target population for this study. AIM: To examine associations between 15 maternal prenatal phthalate metabolite concentrations and children's behavioral problems. METHODS: We quantified phthalate metabolites in maternal urine samples from maternal-child dyads (n = 514) enrolled in the Programming Research in Obesity, Growth Environment and Social Stress (PROGRESS) birth cohort in Mexico City. We performed least absolute shrinkage and selection operator (LASSO) regressions to identify associations between specific-gravity adjusted log2-transformed phthalate metabolites and parent-reported 4-6 year old behavior on the Behavior Assessment System for Children (BASC-2), accounting for metabolite correlations. We adjusted for socio-demographic and birth-related factors, and examined associations stratified by sex. RESULTS: Higher prenatal mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) urinary concentrations were associated with increased hyperactivity scores in the overall sample (β = 0.57, 95% CI = 0.17, 1.13) and in girls (β = 0.54, 95% CI = 0.16, 1.08), overall behavioral problems in boys (β = 0.58, 95% CI = 0.20, 1.15), and depression scores in boys (β = 0.44, 95% CI = 0.06, 0.88). Higher prenatal monobenzyl phthalate (MBzP) concentrations were associated with reduced hyperactivity scores in girls (ß = -0.54, 95% CI = -1.08, -0.21). DISCUSSION: Our findings suggested that prenatal concentrations of phthalates and their replacements altered child neurodevelopment and those associations may be influenced sex.
Authors: Ioanna Katsikantami; Stavros Sifakis; Manolis N Tzatzarakis; Elena Vakonaki; Olga-Ioanna Kalantzi; Aristidis M Tsatsakis; Apostolos K Rizos Journal: Environ Int Date: 2016-09-24 Impact factor: 9.621
Authors: Lizbeth López-Carrillo; Raúl U Hernández-Ramírez; Antonia M Calafat; Luisa Torres-Sánchez; Marcia Galván-Portillo; Larry L Needham; Rubén Ruiz-Ramos; Mariano E Cebrián Journal: Environ Health Perspect Date: 2010-04 Impact factor: 9.031
Authors: Jessie P Buckley; Stephanie M Engel; Joseph M Braun; Robin M Whyatt; Julie L Daniels; Michelle A Mendez; David B Richardson; Yingying Xu; Antonia M Calafat; Mary S Wolff; Bruce P Lanphear; Amy H Herring; Andrew G Rundle Journal: Epidemiology Date: 2016-05 Impact factor: 4.822
Authors: Haotian Wu; Allison J Kupsco; Andrea L Deierlein; Allan C Just; Antonia M Calafat; Emily Oken; Joseph M Braun; Adriana Mercado-Garcia; Alejandra Cantoral; Martha M Téllez-Rojo; Robert O Wright; Andrea A Baccarelli Journal: Environ Sci Technol Date: 2020-01-24 Impact factor: 9.028
Authors: Deborah J Watkins; Michael D McClean; Alicia J Fraser; Janice Weinberg; Heather M Stapleton; Andreas Sjödin; Thomas F Webster Journal: Environ Health Perspect Date: 2011-06-30 Impact factor: 9.031
Authors: Joseph M Braun; Rosalind J Wright; Allan C Just; Melinda C Power; Marcela Tamayo Y Ortiz; Lourdes Schnaas; Howard Hu; Robert O Wright; Martha Maria Tellez-Rojo Journal: Environ Health Date: 2014-06-10 Impact factor: 5.984
Authors: Roni W Kobrosly; Sarah Evans; Amir Miodovnik; Emily S Barrett; Sally W Thurston; Antonia M Calafat; Shanna H Swan Journal: Environ Health Perspect Date: 2014-02-21 Impact factor: 9.031